Roland Duchatelet Net Worth

The estimated Net Worth of Roland Duchatelet is at least $10.5 Tysiąc dollars as of 15 September 2005. Roland Duchatelet owns over 50,000 units of Ontrak Inc stock worth over $10,470 and over the last 21 years Roland sold OTRK stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Roland Duchatelet OTRK stock SEC Form 4 insiders trading

Roland has made over 1 trades of the Ontrak Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Roland exercised 50,000 units of OTRK stock worth $86,500 on 15 September 2005.

The largest trade Roland's ever made was exercising 50,000 units of Ontrak Inc stock on 15 September 2005 worth over $86,500. On average, Roland trades about 6,250 units every 0 days since 2004. As of 15 September 2005 Roland still owns at least 50,000 units of Ontrak Inc stock.

You can see the complete history of Roland Duchatelet stock trades at the bottom of the page.

What's Roland Duchatelet's mailing address?

Roland's mailing address filed with the SEC is C/O CATALYST SEMICONDUCTOR INC, 1250 BORRAGAS AVE, SUNNYVALE, CA, 94089.

Insiders trading at Ontrak Inc

Over the last 22 years, insiders at Ontrak Inc have traded over $61,066,277 worth of Ontrak Inc stock and bought 723,370 units worth $4,767,583 . The most active insiders traders include Nv Elex, Richard J Berman oraz Terren S Acuitas Group Hold.... On average, Ontrak Inc executives and independent directors trade stock every 82 days with the average trade being worth of $15,154. The most recent stock trade was executed by James J Park on 14 June 2024, trading 66 units of OTRK stock currently worth $14.

What does Ontrak Inc do?

ontrak, inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. its ontrak pre (predict-recommend-engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. the company's technology-enabled, ontrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, copd, and congestive heart failure. the ontrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. the company

Complete history of Roland Duchatelet stock trades at Ontrak Inc

Ontrak Inc executives and stock owners

Ontrak Inc executives and other stock owners filed with the SEC include:

• Terren S. Peizer,
  Founder & Exec. Chairman
• Mary Louise Elizabeth Osborne,
  Co-Pres & Chief Commercial Officer
• Brandon H. LaVerne,
  Chief Financial Officer
• Robert I. Newton,
  Gen. Counsel & Sec.
• Curtis Medeiros,
  Pres & COO
• Arik Hill,
  Chief Information Officer
• James J. Park,
  Chief Accounting Officer, CFO & Principal Accounting Officer
• Troy Pospisil,
  Founder & CEO
• Jonathan Edwin Mayhew,
  Chief Exec. Officer
• Peter M Bearse Ph.D.,
  Chief Data Scientist & Sr. VP
• Patrick Traynor,
  Sr. VP of Engineering & Operations
• Susan E. Etzel,
  Sr. VP of Fin.
• Sandy Gyenes,
  Sr. VP of HR
• Jaime Prieto,
  Sr. VP of Marketing
• Sunmi Janicek,
  Chief Compliance & Privacy Officer
• J & W & Co Inc /Ny/Seligman...,
  
• David Paul Eichler,
  VP, Finance and CFO
• Garrett A Garrettson,
  Director
• J & W & Co Inc /Ny/Morris W...,
  
• Glen Possley,
  Director
• Henry C Montgomery,
  Director
• Roland Duchatelet,
  Director
• Spectrum Focus (Master) Fun...,
  10% owner
• Irvin W Kovalik,
  VP Sales
• Gelu Voicu,
  President and CEO
• Sorin Georgescu,
  Vice President Technology
• George Smarandoiu,
  VP Design
• Diane Seloff,
  
• Richard J Berman,
  
• Daniel Hauck,
  VP Worldwide Sales
• Scott M Brown,
  VP,Analog/Mixed Signal Product
• Barry H Wiley,
  VP Corporate Mktg.
• Lionel M Allan,
  Director
• Thomas E Iii Gay,
  VP Finance & Admin, CFO
• Nv Elex,
  10% owner
• Gustavo A Giraldo,
  
• David E Smith,
  10% owner
• Curtis Medeiros,
  Chief Operating Officer
• Sharon Gabrielson,
  Director
• Christopher Shirley,
  Chief Financial Officer
• Edward J Zecchini,
  
• Katherine B Quinn,
  
• Mary Louise Osborne,
  Chief Commercial Officer
• Robert Rebak,
  
• Robert Accordino,
  Chief Medical Officer
• Jonathan E. Mayhew,
  Chief Executive Officer
• Michael Edward Sherman,
  
• James M. Messina,
  
• Brandon H La Verne,
  Interim CEO, COO
• Terren S Acuitas Group Hold...,
  
• Richard A Berman,
  
• Arik Hill,
  Chief Information Officer
• James J Park,
  Chief Financial Officer
• Judith Feld,
  Chief Medical Officer